Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
LSN MS guidelines for the management of multiple sclerosis.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
Multiple sclerosis: Month of birth effect in MS-fact or artefact?
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Central nervous system B-cell lymphoma in multiple sclerosis.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Anti-drug antibodies: B-cell Immunity against therapy.
Is walking capacity in subjects with multiple sclerosis primarily related to muscle oxidative capacity or maximal muscle strength? A pilot study.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
ZOCOR (simvastatin) Tablets
Deep-brain stimulation for Parkinson's disease.
Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
Glial influence on the blood brain barrier.
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Mind-body medicine for multiple sclerosis: a systematic review.
Age and the role of restricted activities in adjustment to disability related pain.
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
Pages
« first
‹ previous
…
302
303
304
305
306
307
308
309
310
…
next ›
last »